Browsing by Author Kosmidis, P.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 64 to 75 of 75 < previous 
TitleAuthor(s)Issue date???itemlist.???
Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG)Skarlos, D. V.; Samantas, E.; Briassoulis, E.; Panoussaki, E.; Pavlidis, N.; Kalofonos, H. P.; Kardamakis, D.; Tsiakopoulos, E.; Kosmidis, P.; Tsavdaridis, D.; Tzitzikas, J.; Tsekeris, P.; Kouvatseas, G.; Zamboglou, N.; Fountzilas, G.24-Nov-2015-
A randomized open-label parallel-group study comparing ondansetron with ondansetron plus dexamethasone in patients with metastatic breast cancer receiving high-dose epirubicin. A Hellenic Cooperative Oncology Group studyJaninis, J.; Giannakakis, T.; Athanasiadis, A.; Fountzilas, G.; Bafaloukos, D.; Kosmidis, P.; Nikolaides, K.; Pavlidis, N.; Skarlos, D.24-Nov-2015-
A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group studyBafaloukos, D.; Linardou, H.; Aravantinos, G.; Papadimitriou, C.; Bamias, A.; Fountzilas, G.; Kalofonos, H. P.; Kosmidis, P.; Timotheadou, E.; Makatsoris, T.; Samantas, E.; Briasoulis, E.; Christodoulou, C.; Papakostas, P.; Pectasides, D.; Dimopoulos, A. M.24-Nov-2015-
A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group studyFountzilas, G.; Dafni, U.; Dimopoulos, M. A.; Koutras, A.; Skarlos, D.; Papakostas, P.; Gogas, H.; Bafaloukos, D.; Kalogera-Fountzila, A.; Samantas, E.; Briasoulis, E.; Pectasides, D.; Maniadakis, N.; Matsiakou, F.; Aravantinos, G.; Papadimitriou, C.; Karina, M.; Christodoulou, C.; Kosmidis, P.; Kalofonos, H. P.24-Nov-2015-
A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group studyFountzilas, G.; Athanassiades, A.; Giannakakis, T.; Briasoulis, E.; Bafaloukos, D.; Kalogera-Fountzila, A.; Onienaoum, A.; Kalofonos, H.; Pectasides, D.; Andreopoulou, E.; Bamia, C.; Kosmidis, P.; Pavlidis, N.; Skarlos, D.24-Nov-2015-
Recombinant interferon ALFA-2A in combination with carboplatin, vinblastine, and bleomycin in the treatment of advanced malignant melanomaBafaloukos, D.; Pavlidis, N.; Fountzilas, G.; Skarlos, D.; Klouvas, G.; Makrantonakis, P.; Giannakakis, T.; Tsavaris, N.; Kosmidis, P.24-Nov-2015-
Subcutaneous low doses of interleukin-2 and recombinant interferon alpha with carboplatin and vinblastine in patients with advanced melanomaBafaloukos, D.; Fountzilas, G.; Skarlos, D.; Pavlidis, N.; Bakoyiannis, C.; Karvounis, N.; Kosmidis, P.24-Nov-2015-
Subsets of tumors responsive to cisplatin or carboplatin combinations in patients with carcinoma of unknown primary site. A Hellenic Cooperative Oncology Group StudyPavlidis, N.; Kosmidis, P.; Skarlos, D.; Briassoulis, E.; Beer, M.; Theoharis, D.; Bafaloukos, D.; Maraveyas, A.; Fountzilas, G.24-Nov-2015-
Treatment of non-small cell lung cancer with gefitinib ('Iressa', ZD1839): the Greek experience with a compassionate-use programRazis, E.; Skarlos, D.; Briasoulis, E.; Dimopoulos, M.; Fountzilas, G.; Lambropoulos, S.; Rigatos, S.; Kopterides, P.; Efstathiou, H.; Tzamakou, E.; Bakoyannis, C.; Pectasides, D.; Makatsoris, T.; Varthalitis, G.; Papadopoulos, S.; Kosmidis, P.24-Nov-2015-
The value of neuroendocrine markers in non-small cell lung cancer: a comparative immunohistopathologic studyKiriakogiani-Psaropoulou, P.; Malamou-Mitsi, V.; Martinopoulou, U.; Legaki, S.; Tamvakis, N.; Vrettou, E.; Fountzilas, G.; Skarlos, D.; Kosmidis, P.; Pavlidis, N.24-Nov-2015-
The Value of Neuroendocrine Markers in Nonsmall Cell Lung-Cancer - a Comparative Immunohistopathologic StudyKiriakogianipsaropoulou, P.; Malamoumitsi, V.; Martinopoulou, U.; Legaki, S.; Tamvakis, N.; Vrettou, E.; Fountzilas, G.; Skarlos, D.; Kosmidis, P.; Pavlidis, N.24-Nov-2015-
Vinblastine and interferon-gamma combination with and without 13-cis retinoic acid for patients with advanced renal cell carcinoma. Results of two phase II clinical trialsBacoyiannis, C.; Dimopoulos, M. A.; Kalofonos, H. P.; Nicolaides, C.; Aravantinos, G.; Bafaloukos, D.; Samelis, G.; Onyenadum, A.; Kiamouris, Ch; Skarlos, D.; Pavlidis, N.; Triantafillidis, A.; Kosmidis, P.24-Nov-2015-